Veech

Veech Therapeutics is a biotechnology company focused on the development of ketone-based metabolic therapies, primarily based on the pioneering research of Dr. Richard L. Veech of the National Institutes of Health. The company specializes in the synthesis and therapeutic application of ketone esters, specifically D-beta-hydroxybutyrate, to treat a variety of metabolic and neurological disorders. These therapies are designed to provide an alternative, more efficient energy source for the brain and heart, potentially addressing conditions where glucose metabolism is impaired, such as Alzheimer's disease and heart failure. Veech Therapeutics aims to leverage the neuroprotective and cardioprotective properties of ketones to improve patient outcomes in chronic and acute disease states. The company's pipeline includes programs targeting traumatic brain injury, Parkinson's disease, and metabolic syndrome.